Impact of Hispanic ethnicity on the clinical presentation and survival of esophageal and gastric cancer in south Florida.

Authors

null

Sofia Palacio

Jackson Memorial Hospital, Miami, FL

Sofia Palacio , Daniel A. Sussman , Bach Ardalan , Caio Max S. Rocha Lima , Peter Joel Hosein

Organizations

Jackson Memorial Hospital, Miami, FL, University of Miami Miller School of Medicine, Miami, FL

Research Funding

No funding sources reported

Background: Race and ethnicity are associated with differences in survival among patients with esophageal and gastric cancer (EGC); outcomes are better in Asian patients but worse for African-Americans compared to Caucasians and Asians. Limited data exist for Hispanics (Hisp) compared to non-Hispanic whites (NHW) or African-Americans (AA). Because of the large Hisp population in South Florida, we compared the clinical presentation and survival of patients with EGC by race and ethnicity. Methods: Using a cross-sectional study design, this IRB-approved analysis of the Florida Cancer Data System database identified all patients diagnosed at the University of Miami and Jackson Memorial Hospital between January 2000 and December 2012 with squamous cell carcinoma (SCC) or adenocarcinoma (AC) of the esophagus, and adenocarcinomas of the gastro-esophageal junction (GEJ) or stomach (STO). Demographic, treatment and survival data were extracted from the registry. Survival was analyzed using the Kaplan-Meier method and variables associated with survival were analyzed using a Cox proportional hazards model. Results: Data from 2,170 patients were available; 44% were Hisp, 19% AA and 38% NHW. Compared to NHW's and AA's, Hisp's were more likely to have the following features: male gender, advanced age at cancer diagnosis, esophageal site of malignancy, adenocarcinoma histology, earlier stage at presentation, history of smoking and alcohol use, private insurance, surgical resection and receipt of chemotherapy (p < 0.001 in each case). Hisp were less likely to have STO (p<0.001). In a multivariate model, race and ethnicity were not independently associated with survival but age, stage, surgical resection and chemotherapy administration were all independently associated with survival (p < 0.01 in each case). Country of birth did not influence results among Hispanic patients. Conclusions: Race and ethnicity were not independently associated with survival in this large registry study. However, significant differences in the tumor location, histology and stage of presentation exist, and further studies to elucidate the biological or environmental reasons for these disparities are warranted.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 125)

DOI

10.1200/jco.2014.32.3_suppl.125

Abstract #

125

Poster Bd #

D31

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Differential burdens: A study of gastric cancer hospitalization and outcomes across race and ethnicities.

First Author: Chun-Wei Pan

Abstract

2024 ASCO Annual Meeting

Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202.

First Author: Kei Muro

Abstract

2023 ASCO Annual Meeting

Racial and ethnic representation in large B-cell lymphoma trials and real-world databases.

First Author: Javier Munoz

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

First Author: Alejandro Nieto Dominguez